View Item 

Show simple item record

Importance of individual activated protein C cleavage site regions in coagulation Factor V for Factor Va inactivation and for Factor Xa activation
dc.contributor.authorHeeb, Mary J.en_US
dc.contributor.authorRehemtulla, Alen_US
dc.contributor.authorMoussalli, Michelineen_US
dc.contributor.authorKojima, Yumien_US
dc.contributor.authorKaufman, Randal J.en_US
dc.date.accessioned2010-04-01T15:52:30Z
dc.date.available2010-04-01T15:52:30Z
dc.date.issued1999-02-05en_US
dc.identifier.citationHeeb, Mary J.; Rehemtulla, Al; Moussalli, Micheline; Kojima, Yumi; Kaufman, Randal J. (1999). "Importance of individual activated protein C cleavage site regions in coagulation Factor V for Factor Va inactivation and for Factor Xa activation." European Journal of Biochemistry 260(1): 64-75. <http://hdl.handle.net/2027.42/66371>en_US
dc.identifier.issn0014-2956en_US
dc.identifier.issn1432-1033en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66371
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10091585&dopt=citationen_US
dc.format.extent914251 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rightsFEBS, 1999en_US
dc.subject.otherActivated Protein Cen_US
dc.subject.otherActivated Protein C Resistanceen_US
dc.subject.otherBlood Coagulationen_US
dc.subject.otherFactor Vaen_US
dc.subject.otherFactor Xaen_US
dc.titleImportance of individual activated protein C cleavage site regions in coagulation Factor V for Factor Va inactivation and for Factor Xa activationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biological Chemistry, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartments of Molecular and Experimental Medicine and of Vascular Biology, The Scripps Research Institute, La Jolla, CA, USA;en_US
dc.contributor.affiliationotherThe Howard Hughes Medical Institute,en_US
dc.identifier.pmid10091585en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66371/1/j.1432-1327.1999.00137.x.pdf
dc.identifier.doi10.1046/j.1432-1327.1999.00137.xen_US
dc.identifier.sourceEuropean Journal of Biochemistryen_US
dc.identifier.citedreferenceRosing, J., Tans, G., Govers-Riemslag, J.W.P., Zwaal, R.F.A., Hemker, H.C. ( 1980 ) The role of phospholipids and factor Va in the prothrombinase complex. J. Biol. Chem. 255, 274 283.en_US
dc.identifier.citedreferenceMann, K.G., Nesheim, M.E., Hibbard, L.S., Tracy, P.B. ( 1981 ) The role of factor V in the assembly of the prothrombinase complex. In Annals of the New York Academy of Sciences ( Walz, D.A. & McCoy, L.E., eds.), pp. 378 388. New York Academy of Sciences, New York.en_US
dc.identifier.citedreferenceTracy, P.B. & Mann, K.G. ( 1983 ) Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va. Proc. Natl Acad. Sci. USA 80, 2380 2384.en_US
dc.identifier.citedreferenceKrishnaswamy, S., Church, W.R., Nesheim, M.E., Mann, K.G. ( 1988 ) Activation of human prothrombin by human prothrombinase: influence of factor Va on the reaction mechanism. J. Biol. Chem. 262, 3291 3299.en_US
dc.identifier.citedreferenceKisiel, W., Canfield, W.M., Ericsson, L.H., Davie, E.W. ( 1977 ) Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 16, 5824 5831.en_US
dc.identifier.citedreferenceOdegaard, B. & Mann, K. ( 1987 ) Proteolysis of factor Va by factor Xa and activated protein C. J. Biol. Chem. 262, 11233 11238.en_US
dc.identifier.citedreferenceSuzuki, K., Stenflo, J.A., DahlbÄck, B., Teodorsson, B. ( 1983 ) Inactivation of human coagulation factor V by activated protein C. J. Biol. Chem. 258, 1914 1920.en_US
dc.identifier.citedreferenceGriffin, J.H., Evatt, B., Zimmerman, T.S., Kleiss, A.J., Wideman, C. ( 1981 ) Deficiency of protein C in congenital thrombotic disease. J. Clin. Invest. 68, 1370 1373.en_US
dc.identifier.citedreferenceBranson, H.E., Katz, J., Marble, R., Griffin, J.H. ( 1983 ) Inherited protein C deficiency and a coumarin-responsive chronic relapsing purpura fulminans syndrome in a neonate. Lancet 2, 1165 1168.en_US
dc.identifier.citedreferenceMannucci, P.M. & Vigano, S. ( 1982 ) Deficiencies of protein C, an inhibitor of blood coagulation. Lancet 2, 463 466.en_US
dc.identifier.citedreferenceBertina, R.M., Broekmans, A.W., van der Linden, I.K., Mertens, K. ( 1982 ) Protein C deficiency in a Dutch family with thrombotic disease. Thromb. Haemost. 48, 1 5.en_US
dc.identifier.citedreferenceDahlbÄck, B., Carlsson, M., Svensson, P.J. ( 1993 ) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl Acad. Sci. USA 90, 1004 1008.en_US
dc.identifier.citedreferenceSvensson, P.J. & DahlbÄck, B. ( 1994 ) Resistance to activated protein C as a basis for venous thrombosis. N. Engl. J. Med. 330, 517 522.en_US
dc.identifier.citedreferenceGriffin, J.H., Evatt, B., Wideman, C., FernÁndez, J.A. ( 1993 ) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82, 1989 1993.en_US
dc.identifier.citedreferenceKoster, T., Rosendaal, F.R., de Ronde, H., Briet, E., Vandenbroucke, J.P., Bertina, R. ( 1993 ) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342, 1503 1506.en_US
dc.identifier.citedreferenceSun, X., Evatt, B., Griffin, J.H. ( 1994 ) Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83, 3120 3125.en_US
dc.identifier.citedreferenceBertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A., Reitsma, P.H. ( 1994 ) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64 67.en_US
dc.identifier.citedreferenceGreengard, J.S., Sun, X., Xu, X., FernÁndez, J.A., Griffin, J.H., Evatt, B. ( 1994 ) Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343, 1361 1362.en_US
dc.identifier.citedreferenceVoorberg, J., Roelse, J., Koopman, R., BÜller, H., Berends, F., ten Cate, J.W., Mertens, K., van Mourik, J.A. ( 1994 ) Association of idiopathic venous thromboembolism with single point-mutation at Arg 506 of factor V. Lancet 343, 1535 1536.en_US
dc.identifier.citedreferenceKoeleman, B.P.C., Reitsma, P.H., Allaart, C.F., Bertina, R.M. ( 1994 ) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84, 1031 1035.en_US
dc.identifier.citedreferenceZÖller, B., He, X., DahlbÄck, B. ( 1995 ) Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb. Haemost. 73, 743 745.en_US
dc.identifier.citedreferenceGandrille, S., Greengard, J.S., Alhenc-Gelas, M., Juhan-Vague, I., Abgrall, J.F., Jude, B., Griffin, J.H., Aiach, M. & French Network on the behalf of INSERM ( 1995 ) Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 86, 219 224.en_US
dc.identifier.citedreferenceBrenner, B., Zivelin, A., Lanir, N., Greengard, J.S., Griffin, J.H., Seligsohn, U. ( 1996 ) Venous thromboembolism associated with double heterozygosity for R506Q: mutation of factor V and for T298M: mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood 88, 877 880.en_US
dc.identifier.citedreferenceKalafatis, M. & Mann, K.G. ( 1993 ) Role of the membrane in the inactivation of factor Va by activated protein C. J. Biol. Chem. 268, 27246 27257.en_US
dc.identifier.citedreferenceKalafatis, M., Rand, M.D., Mann, K.G. ( 1994 ) The mechanism of inactivation of human factor V and human factor Va by activated protein C. J. Biol. Chem. 269, 31869 31880.en_US
dc.identifier.citedreferenceRosing, J., Hoekema, L., Nicolaes, G.A.F., Thomassen, M.C.L.G.D., Hemker, H.C., Varadi, K., Schwarz, H.P., Tans, G. ( 1995 ) Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor Va R506Q by activated protein C. J. Biol. Chem. 270, 27852 27858.en_US
dc.identifier.citedreferenceKalafatis, M., Bertina, R.M., Rand, M.D., Mann, K.G. ( 1995 ) Characterization of the molecular defect in factor V R506Q. J. Biol. Chem. 270, 4053 4057.en_US
dc.identifier.citedreferenceHeeb, M.J., Kojima, Y., Greengard, J., Griffin, J.H. ( 1995 ) Activated protein C resistance: molecular mechanisms based on studies using purified Gln 506 -factor V. Blood 85, 3405 3411.en_US
dc.identifier.citedreferenceNicolaes, G.A.F., Tans, G., Thomassen, M.C.L.G.D., Hemker, H.C., Pabringer, I., Varadi, K., Schwarz, H.P., Rosing, J. ( 1995 ) Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor Va R506Q by activated protein C. J. Biol. Chem. 270, 21158 21166.en_US
dc.identifier.citedreferencePittman, D.D. & Kaufman, R.J. ( 1993 ) Site-directed mutagenesis and expression in mammalian cells to evaluate structure–function relationships in coagulation factors V and VIII. Methods Enzymol. 222, 236 260.en_US
dc.identifier.citedreferenceMarquette, K.A., Pittman, D.D., Kaufman, R.J. ( 1995 ) The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain. Blood 86, 3026 3034.en_US
dc.identifier.citedreferenceKeller, F.G., Ortel, T.L., Quinn-Allen, M.A., Kane, W.H. ( 1995 ) Thrombin-catalyzed activation of recombinant human factor V. Biochemistry 34, 4118 4124.en_US
dc.identifier.citedreferenceEgan, J.O., Kalafatis, M., Mann, K.G. ( 1997 ) The effect of Arg 306 → Ala and Arg 506 → Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. Protein Sci. 6, 2016 2027.en_US
dc.identifier.citedreferenceYan, T.L., Cui, J., Rehemtulla, A., Yang, A., Moussalli, M., Kaufman, R.J., Ginsburg, D. ( 1998 ) The structure and function of murine factor V and its inactivation by protein C. Blood 91, 4593 4599.en_US
dc.identifier.citedreferenceThorelli, E., Kaufman, R.J., Dahlback, B. ( 1997 ) Cleavage requirements for activation of factor V by factor Xa. Eur. J. Biochem. 247, 12 20.en_US
dc.identifier.citedreferenceHeeb, M.J., Rehemtulla, A., Moussalli, M., Kojima, Y., Griffin, J.H., Kaufman, R.J. ( 1996 ) Importance of individual activated protein C cleavage sites in the heavy chain of factor V and Va. Blood 88, 440a.en_US
dc.identifier.citedreferenceHeeb, M.J., Rehemtulla, A., Moussalli, M., Kojima, Y., Griffin, J.H. ( 1997 ). Arginine-306 is the most important activated protein C cleavage site for efficient inactivaiton of factor Va, but not of factor V. Thromb Haemostas ( Suppl. ) 598 (Abstract).en_US
dc.identifier.citedreferenceGruber, A., Griffin, J.H., Harker, L., Hanson, S.R. ( 1989 ) Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 73, 639 642.en_US
dc.identifier.citedreferenceTans, G., Rosing, J., Thomassen, M.C., Heeb, M.J., Zwaal, R.F.A., Griffin, J.H. ( 1991 ) Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 77, 2641 2648.en_US
dc.identifier.citedreferenceDiScipio, R.G., Hermodson, M.A., Yates, S.G., Davie, E.W. ( 1977 ) A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 16, 698 706.en_US
dc.identifier.citedreferenceHeeb, M.J., Mesters, R.M., Tans, G., Rosing, J., Griffin, J.H. ( 1993 ) Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J. Biol. Chem. 268, 2872 2877.en_US
dc.identifier.citedreferenceKaufman, R.J., Davies, M.V., Wasley, L.C., Michnick, D. ( 1991 ) Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res. 19, 4485 4490.en_US
dc.identifier.citedreferenceNesheim, M.E., Eid, S., Mann, K.G. ( 1981 ) Assembly of the prothrombinase complex in the absence of prothrombin. J. Biol. Chem. 256, 9874 9882.en_US
dc.identifier.citedreferenceMesters, R.M., Houghten, R.A., Griffin, J.H. ( 1991 ) Identification of a sequence of human activated protein C (residues 390–404) essential for its anticoagulant activity. J. Biol. Chem. 266, 24514 24519.en_US
dc.identifier.citedreferencePittman, D.D., Marquette, K.A., Kaufman, R.J. ( 1994 ) Role of the B-domain for factor VIII and factor V expression and function. Blood 84, 4214 4225.en_US
dc.identifier.citedreferenceMonkovic, D.D. & Tracy, P.B. ( 1990 ) Activation of human factor V by factor Xa and thrombin. Biochemistry 29, 1118 1128.en_US
dc.identifier.citedreferenceMann, K.G., Hockin, M.F., Begin, K.J., Kalafatis, M. ( 1997 ) Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J. Biol. Chem. 272, 20678 20683.en_US
dc.identifier.citedreferenceFernÁndez, J.A., Hackeng, T.M., Kojima, K., Griffin, J.H. ( 1997 ) The carbohydrate moiety of factor V modulates inactivation by activated protein C. Blood 89, 4348 4354.en_US
dc.identifier.citedreferenceRosing, J., Bakker, H., Thomassen, M.C.L.G.D., Thomassen, L., Hemker, H., Tans, G. ( 1993 ) Characterization of two forms of human factor Va with different cofactor activities. J. Biol. Chem. 268, 21130 21136.en_US
dc.identifier.citedreferenceOrtel, T.L., Quinn-Allen, M.A., Keller, F.G., Peterson, J.A., Larocca, D., Kane, W.H. ( 1994 ) Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras. J. Biol. Chem. 269, 15898 15905.en_US
dc.identifier.citedreferenceKalafatis, M., Rand, M.D., Jenny, R.J., Ehrlich, Y.H., Mann, K.G. ( 1993 ) Phosphorylation of factor Va and factor VIIIa by activated platelets. Blood 81, 704 719.en_US
dc.identifier.citedreferencePittman, D.D., Tomkinson, K.N., Michnick, D., Selighsohn, U., Kaufman, R.J. ( 1994 ) Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity. Biochemistry 33, 6952 6959.en_US
dc.identifier.citedreferenceChan, W.P., Lee, C.K., Kwong, Y.L., Lam, C.K., Liang, R. ( 1998 ) A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91, 1135 1139.en_US
dc.identifier.citedreferenceWilliamson, D., Brown, K., Luddington, R., Baglin, C., Baglin, T. ( 1998 ) Factor V Cambridge: a new mutation (Arg 306 →Thr) associated with resistance to activated protein C. Blood 91, 1140 1144.en_US
dc.identifier.citedreferenceWei, C.-J., Quinn-Allen, M.-A., Kane, W.H. ( 1995 ) Cleavage at arginine 306 is not required for inactivation of factor V by activated protein C (APC). Blood 86, 615a. (Abstract).en_US
dc.identifier.citedreferenceGale, A.J., Sun, X., Heeb, M.J., Griffin, J.H. ( 1997 ) Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va. Protein Sci. 6, 132 140.en_US
dc.identifier.citedreferenceHeeb, M.J., Kojima, Y., Hackeng, T.M., Griffin, J.H. ( 1996 ) Binding sites for blood coagulation factor Xa and protein S involving residues 493–506 in factor Va. Protein Sci. 5, 1883 1889.en_US
dc.identifier.citedreferenceKojima, Y., Heeb, M.J., Gale, A., Hackeng, T.M., Griffin, J.H. ( 1998 ) Binding sites for coagulation factor Xa involving residues 311–335 in factor Va. J. Biol. Chem. 273, 14900 14905.en_US
dc.identifier.citedreferencePemberton, S., Lindley, P., Zaitsev, V., Card, G., Tuddenham, E.G.D., Kemball-Cook, G. ( 1997 ) A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood 89, 2413 2421.en_US
dc.identifier.citedreferenceHeeb, M.J., Kojima, Y., Hackeng, T.M., Griffin, J.H. ( 1994 ) Functional studies of factor Va residues 493–506 related to activated protein C resistance. Blood 84, 391a. (Abstract).en_US
dc.identifier.citedreferenceMesters, R.M., Heeb, M.J., Griffin, J.H. ( 1993 ) Interactions and inhibition of blood coagulation factor Va involving residues 311–325 of activated protein C. Protein Sci. 2, 1482 1489.en_US
dc.identifier.citedreferenceKojima, Y., Heeb, M.J., Hackeng, T.M., Gale, A., Griffin, J.H. ( 1997 ) Binding sites for coagulation factor Xa and activated protein C involving residues 311–335 in factor Va. Thromb. Haemost. ( Suppl. ) June, 423 424 (Abstract).en_US
dc.identifier.citedreferenceNesheim, M.E., Canfield, W.M., Kisiel, W., Mann, K.G. ( 1982 ) Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J. Biol. Chem. 257, 1443 1447.en_US
dc.identifier.citedreferenceYe, J. & Esmon, C.T. ( 1995 ) Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: an experimental and theoretical approach. Biochemistry 34, 6448 6453.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1432-1327.1999.00137.x.pdf
Size:
892.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.